Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Thomas R. Pieber, Bruce W. Bode, Young Min Cho, Erik Christiansen et autres
at, us, kr, be, dk (code pays fourni par la source)